MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹23 Cr | ₹29 Cr | ₹42 Cr | ₹41 Cr | ₹19 Cr |
What is the latest Total Debt ratio of MARKSANS PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹19 Cr |
How is Total Debt of MARKSANS PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | -20.65 | |
| Mar2024 | ₹29 Cr | -30.05 | |
| Mar2023 | ₹42 Cr | 0.72 | |
| Mar2022 | ₹41 Cr | 120.34 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Debt of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,107.7 Cr | 2.4% | 3.4% | -9.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 2.4% |
3.4% |
-9.6% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses